15 "Mysteries Of The Human Body" That — According To Doctors — Science Still Doesn't Have An Explanation For

I just took this common pain medication...and I was today years old when I learned we don't actually know how it works. 😳 ...
MedPage Today

Interim Data Support Elafibranor in Rare Chronic Liver Disease

Elafibranor (Iqirvo) was well tolerated and led to sustained improvements in liver enzyme levels and itch severity through 28 weeks in patients with primary sclerosing cholangitis (PSC), according to ...
Kauppalehti

[Ad hoc announcement pursuant to Art. 53 LR] Roche’s fenebrutinib shows unprecedented positive Phase III results as the potential first and only BTK inhibitor in both ...

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
STAT

New AHA leader sees AI as way to address cardiology’s blind spot: women

"In general, health care was designed by men for men," says Stacey Rosen, president of the American Heart Association. She ...
Medical Dialogues

Eloralintide-Long-Acting Amylin Receptor Agonist Shows Significant Weight Loss in Obesity in a Phase 2 Trial

Amylin receptor agonists are gaining attention as a new class of anti-obesity drugs. Eloralintide, a novel and selective long ...
Sportschosun on MSN

Measuring the degree of liver cancer immune cell exhaustion and predicting the effectiveness of immu...

Professor Jang Jung-won of the Department of Gastroenterology at Seoul St. Mary's Hospital of Catholic University and ...